Social Anxiety Disorder
Conditions
Keywords
cognitive behavioral therapy;, guided self-help, adolescent
Brief summary
The primary objectives of this study is to test the feasibility and efficacy of group-therapy supported internet-delivered CBT for adolescents (13 - 17 years) with social anxiety disorder. Investigators will conduct an open trial with N = 30 participants. Participants will be assessed at baseline, immediately after treatment and at a 6-month follow-up.
Detailed description
Social anxiety disorder (SAD) among youths is highly prevalent and causes significant impairment in the lives of the affected. In spite of CBT being the most effective treatment, evidence suggests that many young people with this disorder do not have access to good-quality CBT. Internet-based CBT is, as numerous prior studies have shown, an effective method to treat psychiatric conditions in adults, but little is known about ICBT for adolescents and there are but a few controlled studies on ICBT for children and adolescents with anxiety disorders. This pilot trial will evaluate the feasibility and efficacy of a blended ICBT-treatment where internet-based and group-based sessions are combined. Furthermore, as ICBT is a novel format in the treatment of psychological problems in young people, it is essential to evaluate the feasibility and acceptability of the technical solutions that carry the active treatment. The study will also include genotyping of participants to further our understanding of etiology of SAD and to explore the relationship between genetic variations and treatment outcome. Additionally, as there is little known about the affect of ASD symptoms on treatment outcome in face-to-face CBT in general, and in ICBT in particular, the association between autistic traits and treatment outcome will be evaluated. Lastly, the role of attentional processes in the maintenance of social anxiety has been scarcely studied and an aim with the current study is to further our understanding of the cognitive factors that underlie SAD
Interventions
BEHAVIORALGroup-therapy + ICBT
The group therapy supported ICBT treatment program is a combined web-based and face-to-face intervention that will involve adolescents as well as their parents. The program is founded on and inspired by previously evaluated and evidence-based interventions. Altogether, adolescents go through 12 chapters/sessions, 3 of which are face-to-face group sessions at the research clinic, and 9 of which are web-bases chapters. The program is divided into three different phases, starting with psychoeducation regarding social anxiety and the rationale for a cognitive behavioral intervention. Phase two is the main part of treatment and contains behavioral interventions, mainly exposure and habituation to feared situations and/or stimuli.
Sponsors
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* A principal diagnosis of social anxiety disorder, as defined by DSM-5 * Ability to read and write Swedish * Daily access to the internet through a computer or similar device * A parent or caregiver that is able to co-participate in the treatment * Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
Exclusion criteria
* Diagnosed with autism spectrum disorder, psychosis, bipolar disorder or severe eating disorder * Present risk of suicide * Ongoing substance dependence * Occurrence of domestic violence * Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Global Impression - Severity | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | Change from Baseline of social anxiety disorder severity, after 12 weeks and at 6 months after treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospital Anxiety and Depression Scale (HADS) | Assessed at baseline. | — |
| Social Responsiveness Scale - Parent version | Assessed at baseline. | — |
| DNA through saliva sampling | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Attention bias when presented with social stimuli (eye-tracking) | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Qualitative interviews of experience from treatment | Assessed at 12 weeks after treatment starts | — |
| Presence of DSM-5 Social Anxiety Disorder | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Clinical Global Impression - Improvement | Assessed 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Social Phobia and Anxiety Inventory (SPAI) - Child version | Assessed at baseline, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Social Phobia and Anxiety Inventory (SPAI) - Parent version | Assessed at baseline, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Revised Children´s Anxiety and Depression Scale (RCADS) - Child version | Assessed at baseline, Mid-6 weeks, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Revised Children´s Anxiety and Depression Scale (RCADS) - Parent version | Assessed at baseline, mid-6 weeks, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Technology acceptance scale (TAS) - parent version | Assessed at Mid-3 week and 12 weeks after treatment starts | — |
| Social Phobia Weekly Summary Scale (SPWSS) | Assessed at baseline, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Patient ICBT Adherence Scale (PIAS) | Assessed at Mid-6 weeks and 12 weeks after treatment starts | — |
| KIDSCREEN-10 - Child version | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| KIDSCREEN-10 - Parent version | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Education, Work and Social Adjustment Scale - child version | Assessed at baseline, Mid-6 week, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Education, Work and Social Adjustment Scale - parent version | Assessed at baseline, Mid-6 week, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version (TiC-P) | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
| Client Satisfaction Scale (CSS) | Assessed at 12 weeks after treatment starts | — |
| Measurement of anxiety levels during exposure (app) | Assessed from Mid-4 week to 12 weeks after treatment starts | — |
| Unintended treatment effects | Assessed at 12 weeks after treatment starts | Open ended question where participants report any possible negative consequence of the treatment |
| Technology acceptance scale (TAS) - child version | Assessed at Mid-3 week and 12 weeks after treatment starts | — |
| Children's Global Assessment Scale (CGAS) | Assessed at baseline, 12 weeks after treatment starts and 6 months after treatment has ended | — |
Countries
Sweden
Outcome results
None listed